COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,283 Articles (22,759 medRxiv, 8,524 bioRxiv)

Most recent first Previous |  Page 1112: Articles 11111-11120  | Next

Analytical sensitivity and effectiveness of different SARS-CoV-2 testing options
Lelie, N., Koppelman, M., Van Drimmelen, H., Bruisten, S.
10.1101/2021.11.26.21265946 — Posted: 2021-11-28
A generic method and software to estimate the transmission advantage of pathogen variants in real-time : SARS-CoV-2 as a case-study
Bhatia, S., Wardle, J., Nash, R. K., Nouvellet, P., Cori, A.
10.1101/2021.11.26.21266899 — Posted: 2021-11-28
Dosing interval strategies for two-dose COVID-19 vaccination in 13 low- and middle-income countries of Europe: health impact modelling and benefit-risk analysis
Liu, Y., Pearson, C. A., Sandmann, F. G., Barnard, R. C., Kim, J.-H., CMMID COVID-19 Working Group, , Flasche, S., Jit, M., Abbas, K.
10.1101/2021.11.27.21266930 — Posted: 2021-11-28
Variations of the quality of care during the COVID-19 pandemic affected the mortality rate of non-COVID patients with hip fracture
Golinelli, D., Sanmarchi, F., Capodici, A., Gribaudo, G., Altini, M., Rosa, S., Esposito, F., Fantini, M. P., Lenzi, J.
10.1101/2021.11.27.21266927 — Posted: 2021-11-28
The relationship of COVID-19 related stress and media consumption with schizotypy, depression and anxiety
Daimer, S., Mihatsch, L., Neufeld, S. A., Murray, G. K., Knolle, F.
10.1101/2021.11.26.21266896 — Posted: 2021-11-28
Synthesis of High-Resolution Research-Quality MRI Data from Clinical MRI Data in Patients with COVID-19
Cali, R. J., Freeman, H. J., Billot, B., Barra, M. E., Fischer, D., Sanders, W. R., Huang, S. Y., Conklin, J., Fischl, B., Iglesias, J. E., Edlow, B. L.
10.1101/2021.11.25.21266090 — Posted: 2021-11-26
Population-level changes in the mental health of UK workers during the COVID-19 pandemic: A longitudinal study using Understanding Society
Kromydas, T., Green, M. J., Craig, P., Katikireddi, S. V., Leyland, A. H., Niedzwiedz, C. L., Pearce, A., Thomson, R. M., Demou, E. L.
10.1101/2021.11.25.21266866 — Posted: 2021-11-26
The COVID-19 pandemic and temporal change in metabolic risk factors for cardiovascular disease: a natural experiment within the HELIUS study.
Hummel, B., Yerkes, M., Harskamp, R. E., Galenkamp, H., Kunst, A. E., Lok, A., van Valkengoed, I. G. M.
10.1101/2021.11.25.21266856 — Posted: 2021-11-26
Changes in antidepressant use in Australia: A nationwide analysis prior to and during the COVID-19 pandemic (2015-2021)
de Oliveira Costa, J., Gilles, M. B., Schaffer, A. L., Peiris, D., Zoega, H., Pearson, S.-A.
10.1101/2021.11.24.21266837 — Posted: 2021-11-26
Pandemic inequity in a megacity: a multilevel analysis of individual, community, and health care vulnerability risks for COVID-19 mortality in Jakarta, Indonesia
Surendra, H., Salama, N., Lestari, K. D., Adrian, V., Widyastuti, W., Oktavia, D., Lina, R. N., Djaafara, B. A., Fadilah, I., Sagara, R., Ekawati, L. L., Nurhasim, A., Ahmad, R. A. A., Kekalih, A., Syam, A. F., Shankar, A. H., Thwaites, G., Baird, J. K., Hamers, R. L., Elyazar, I. R.
10.1101/2021.11.24.21266809 — Posted: 2021-11-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).